| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2025 | Mar 26, 2025 | Trevi Therapeutics, Inc. | Chief Scientific Officer | Sell | 26.3 | -2,631 | -1.17% | ✗ | $17.4K |
| Aug 19, 2024 | Aug 21, 2024 | Trevi Therapeutics, Inc. | Chief Scientific Officer | Sell | 26.3 | -16,496 | -6.97% | ✗ | $48.9K |
| Aug 14, 2024 | Aug 16, 2024 | Trevi Therapeutics, Inc. | Chief Scientific Officer | Sell | 22.5 | -31,505 | -4.55% | ✗ | $87.2K |
| May 29, 2024 | May 31, 2024 | Trevi Therapeutics, Inc. | Chief Scientific Officer | Sell | 42.5 | -53,368 | -19.93% | ✗ | $136.1K |